Genocea Biosciences Inc (GNCA) Up 3.33% in Premarket Trading

Tuesday, January 04, 2022 07:30 AM | InvestorsObserver Analysts

Mentioned in this article

Genocea Biosciences Inc (GNCA) Up 3.33% in Premarket Trading

Genocea Biosciences Inc (GNCA) is higher by Tuesday morning, with the stock increasing 3.33% in pre-market trading to 1.24. GNCA's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, the stock ranks higher than 47% of stocks. Genocea Biosciences Inc has risen 7.14% over the past month, closing at $1.17 on December 7. During this period of time, the stock fell as low as $0.95 and as high as $1.48. GNCA has an average analyst recommendation of Strong Buy. The company has an average price target of $6.38.

GNCA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on GNCA!

See Full GNCA Report

Genocea Biosciences Inc has a Long-Term Technical rank of 4. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 96% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, GNCA ranks better than 11% of stocks.

Important Dates for Investors in GNCA:

-Genocea Biosciences Inc is set to release earnings on 1/26/2022. During their last earnings release the company posted EPS of $-0.53. -We do not have a set dividend date for Genocea Biosciences Inc at this time. Click Here To Get The Full Report on Genocea Biosciences Inc (GNCA)